Human <scp>EGFRvIII</scp> chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma

Abstract

This study demonstrates the preclinical functionality of a highly specific CAR targeting EGFRvIII on human cells. This CAR could be an effective treatment for glioblastoma and warrants future clinical investigation.